hVIVO plc (HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, announced its unaudited interim results for the six months ended 30 June 2026.
RNS Hotlist with Zak Mir: HALO, TUN, SRVL, GNIP, TOO, GENI, IBAI, MCB, CGO, KR1 & POW
The Telegraph: Treasury analysis ‘shows wealth tax would lose money’ Further increases to capital gains tax will lead to lower receipts, Tories claim
RNS Hotlist with Zak Mir: SSIT, TUN, RMR, IBAI, WCAT, CINH, SBDS, UFO, ROCK, BOOM, FCM, ATM, OMI, CPAI & FDR
The Telegraph: Billions in aid handed to terrorists and criminals. Secret dossier reveals foreign aid and Covid relief loans were appropriated by gangs and hostile states
Share Talk Weekly Stock Market News Review, Sunday 7th June 2026
London markets ended the week on a mixed note as gains in the FTSE 100 were offset by weakness in mining shares, while stronger-than-expected US jobs data triggered a sell-off
RNS Hotlist with Zak Mir: AVCT, IBAI, ALRT, KEN, BMV, RPI, IOF, FORG & CTL
Avacta Therapeutics (AVCT), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, announced that it has raised gross proceeds of approximately £9 million from institutional investors and existing